Close

Oppenheimer Starts China Kanghui Holdings (KH) at Outperform; An Emerging Orthopedic Company w/Eyes on Global Market

November 22, 2011 8:08 AM EST
Get Alerts KH Hot Sheet
Price: $30.60 --0%

Rating Summary:
    5 Buy, 1 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 11 | Down: 12 | New: 13
Join SI Premium – FREE
Oppenheimer initiates coverage on China Kanghui Holdings (NYSE: KH) with a Outperform. PT $20.00.

Oppenheimer analyst says, "KH ranks No. 2 among domestic players in China's trauma and spine implant market. Now, armed with joint products from its partners, KH plans to enter the fast-growing reconstruction market in 2012. We view China's orthopedic market as attractive, and expect it to grow at 16%
2010-2015 CAGR, far outpacing a worldwide 3.8%. As a leading player, in our view, Kanghui presents the best investment vehicle to gain exposure to the industry's secular growth trend. We estimate Kanghui to grow revenue/EPADS at 25.1%/23.5% 2011-2013 CAGRs and recommend building positions ahead of joint product launches. Our PT conservatively assumes a 17x P/E multiple on our 2013E EPADS."

For an analyst ratings summary and ratings history on China Kanghui Holdings click here. For more ratings news on China Kanghui Holdings click here.

Shares of China Kanghui Holdings closed at $14.76 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

New Coverage